Frontiers in Cellular and Infection Microbiology

Papers
(The H4-Index of Frontiers in Cellular and Infection Microbiology is 65. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development584
Antibiotics as Major Disruptors of Gut Microbiota438
Antimicrobial Peptides: A New Hope in Biomedical and Pharmaceutical Fields260
Role and Mechanism of Gut Microbiota in Human Disease252
Antibiotic Resistance: One Health One World Outlook251
Fungi vs. Fungi in Biocontrol: An Overview of Fungal Antagonists Applied Against Fungal Plant Pathogens225
Roseburia intestinalis: A Beneficial Gut Organism From the Discoveries in Genus and Species200
Probiotic Gastrointestinal Transit and Colonization After Oral Administration: A Long Journey184
The Gut Microbiota in Inflammatory Bowel Disease157
SARS-COV-2 Variants: Differences and Potential of Immune Evasion156
The Female Vaginal Microbiome in Health and Bacterial Vaginosis155
Periodontal Disease: The Good, The Bad, and The Unknown148
Global Threat of Carbapenem-Resistant Gram-Negative Bacteria133
Cytokine Profiles Associated With Acute COVID-19 and Long COVID-19 Syndrome128
Wuhan to World: The COVID-19 Pandemic125
Urinary Microbiome: Yin and Yang of the Urinary Tract123
T-Helper Cell Subset Response Is a Determining Factor in COVID-19 Progression113
Blood-Brain Barrier Disruption by Lipopolysaccharide and Sepsis-Associated Encephalopathy112
The Building Blocks of Antimicrobial Resistance in Pseudomonas aeruginosa: Implications for Current Resistance-Breaking Therapies109
Mechanism of the Gut Microbiota Colonization Resistance and Enteric Pathogen Infection106
Cathepsin L in COVID-19: From Pharmacological Evidences to Genetics106
Virulence Factors of Pseudomonas Aeruginosa and Antivirulence Strategies to Combat Its Drug Resistance105
Impact of Gut Microbiota and Microbiota-Related Metabolites on Hyperlipidemia104
Gut Microbiota: An Important Player in Type 2 Diabetes Mellitus104
Desulfovibrio Bacteria Are Associated With Parkinson’s Disease104
The Role of Porphyromonas gingivalis Outer Membrane Vesicles in Periodontal Disease and Related Systemic Diseases100
The Gut Microbiota (Microbiome) in Cardiovascular Disease and Its Therapeutic Regulation99
Gut Microbiota and Diarrhea: An Updated Review98
SARS-CoV-2 Infects Endothelial Cells In Vivo and In Vitro97
Chitosan-Based Nanoparticles Against Viral Infections97
Effect of Fecal Microbiota Transplantation on Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial95
Recent Advances in Molecular Diagnostics of Fungal Plant Pathogens: A Mini Review93
An Update on Molecular Diagnostics for COVID-1993
Dysbiosis and Implication of the Gut Microbiota in Diabetic Retinopathy91
Escherichia coli as a Multifaceted Pathogenic and Versatile Bacterium90
Contribution of Lactobacillus iners to Vaginal Health and Diseases: A Systematic Review90
Viral Infections, the Microbiome, and Probiotics88
Gut Microbiota Status in COVID-19: An Unrecognized Player?86
Gut Microbiota-Derived Metabolites in Irritable Bowel Syndrome81
Understanding bacterial biofilms: From definition to treatment strategies80
The Impact of Gut Microbiota on Radiation-Induced Enteritis78
Application of Metagenomic Next-Generation Sequencing in the Diagnosis of Pulmonary Infectious Pathogens From Bronchoalveolar Lavage Samples78
Recent advances in recombinase polymerase amplification: Principle, advantages, disadvantages and applications78
Brief Overview of Approaches and Challenges in New Antibiotic Development: A Focus On Drug Repurposing76
Galleria mellonella as a Suitable Model of Bacterial Infection: Past, Present and Future76
Herpes Simplex Virus Cell Entry Mechanisms: An Update75
Role of Gut Microbiome in Autism Spectrum Disorder and Its Therapeutic Regulation74
Klebsiella pneumoniae Biofilms and Their Role in Disease Pathogenesis74
Bacterial Vaginosis: What Do We Currently Know?73
Clinical Experience of Personalized Phage Therapy Against Carbapenem-Resistant Acinetobacter baumannii Lung Infection in a Patient With Chronic Obstructive Pulmonary Disease71
Mycobacterium abscessus complex: A Review of Recent Developments in an Emerging Pathogen71
The Microbiota of the Human Mammary Ecosystem70
Oxidative Stress and Pathogenesis in Malaria70
Antibiotic Resistance and Virulence Profiles of Klebsiella pneumoniae Strains Isolated From Different Clinical Sources70
Bacteriocin-Producing Probiotic Lactic Acid Bacteria in Controlling Dysbiosis of the Gut Microbiota69
Detection of Antibiotic-Resistance by MALDI-TOF Mass Spectrometry: An Expanding Area68
Fecal Microbiota Transplantation Relieves Gastrointestinal and Autism Symptoms by Improving the Gut Microbiota in an Open-Label Study68
The Gut Microbiota of Critically Ill Patients With COVID-1968
Coronavirus Disease (COVID-19) Caused by (SARS-CoV-2) Infections: A Real Challenge for Human Gut Microbiota68
Colon Carcinogenesis: The Interplay Between Diet and Gut Microbiota67
Antimicrobial Activity of Lemongrass Essential Oil (Cymbopogon flexuosus) and Its Active Component Citral Against Dual-Species Biofilms of Staphylococcus aureus and Candida Species67
Cutaneous Malassezia: Commensal, Pathogen, or Protector?66
Metabolic Implications of Oxidative Stress and Inflammatory Process in SARS-CoV-2 Pathogenesis: Therapeutic Potential of Natural Antioxidants66
Pulsatilla chinensis Saponins Ameliorate Inflammation and DSS-Induced Ulcerative Colitis in Rats by Regulating the Composition and Diversity of Intestinal Flora65
COVID-19 Pandemic and Vaccines Update on Challenges and Resolutions65
Breath Biopsy and Discovery of Exclusive Volatile Organic Compounds for Diagnosis of Infectious Diseases65
0.05682897567749